Aflac（AFL）株式概要
アフラック・インコーポレーテッドはその子会社を通じて医療・生命保険商品を提供している。 詳細
AFL Community Fair Values
Create NarrativeSee what 63 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Aflac Incorporated 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$115.47 |
| 52週高値 | US$119.81 |
| 52週安値 | US$96.95 |
| ベータ | 0.61 |
| 1ヶ月の変化 | -1.99% |
| 3ヶ月変化 | 8.71% |
| 1年変化 | 11.78% |
| 3年間の変化 | 71.98% |
| 5年間の変化 | 112.97% |
| IPOからの変化 | 194,035.75% |
最新ニュース
分析記事 • 17h
Aflac (AFL) Stock Could Be 31% Undervalued Even As Another View Sees It Overpriced
Aflac (AFL) is back on investors’ radar after recent share price weakness, with the stock down over the past month while still showing stronger performance over the past 3 months and year. See our latest analysis for Aflac. At around $115 per share, Aflac’s recent 1 month share price return of 2.5% down contrasts with its 3 month share price return of 8.7% and 1 year total shareholder return of 14.9%. This hints that shorter term momentum is cooling after a solid multi year run. If this shift...
ナラティブの更新 • Jun 10
AFL: Future Returns Will Reflect Mixed Carrier Tailwinds And Cautious Earnings Expectations
Aflac's updated fair value edges up by about $0.36 to roughly $112.43 as analysts factor in higher Street price targets that reflect stronger recent stock performance and generally firm Q1 underwriting and earnings trends across insurers. Analyst Commentary Recent Street research around Aflac shows a mix of optimism and caution, with several firms adjusting price targets in both directions as they reassess valuation and execution after first quarter results.ナラティブの更新 • May 26
AFL: Future Returns Will Balance Carrier Focus With Cautious Earnings Assumptions
Analysts have raised their blended price target for Aflac by about $0.20 per share, citing recent stock performance, generally strong life insurance results in Q1, and roll-forward valuation work that now places greater emphasis on carriers rather than brokers. Analyst Commentary Recent Street research on Aflac shows a mix of optimism around execution and caution around valuation and earnings power, with several price target changes in both directions.Seeking Alpha • May 06
Aflac: An Insurer To Buy After Impressive Q1 Results, Even As Valuation Rises
Summary Aflac remains a Buy despite a Q1 earnings miss, supported by organic policy growth, proven dividend increases, and robust balance sheet strength. Growth catalysts include new policy sales, expanding Asian market presence, and niche segments like pet insurance, though revenue trends remain uneven. Margins and expense ratios are favorable, with A-level credit ratings and conservative leverage, but forward P/E multiples signal some overvaluation and more muted near-term upside. Dividend growth (+16% YoY) and a low payout ratio (~30%) reinforce AFL's appeal for income investors, while technicals support a bullish trend as well after a recovery signal. Read the full article on Seeking AlphaRecent updates
分析記事 • 17h
Aflac (AFL) Stock Could Be 31% Undervalued Even As Another View Sees It Overpriced
Aflac (AFL) is back on investors’ radar after recent share price weakness, with the stock down over the past month while still showing stronger performance over the past 3 months and year. See our latest analysis for Aflac. At around $115 per share, Aflac’s recent 1 month share price return of 2.5% down contrasts with its 3 month share price return of 8.7% and 1 year total shareholder return of 14.9%. This hints that shorter term momentum is cooling after a solid multi year run. If this shift...ナラティブの更新 • Jun 10
AFL: Future Returns Will Reflect Mixed Carrier Tailwinds And Cautious Earnings Expectations
Aflac's updated fair value edges up by about $0.36 to roughly $112.43 as analysts factor in higher Street price targets that reflect stronger recent stock performance and generally firm Q1 underwriting and earnings trends across insurers. Analyst Commentary Recent Street research around Aflac shows a mix of optimism and caution, with several firms adjusting price targets in both directions as they reassess valuation and execution after first quarter results.ナラティブの更新 • May 26
AFL: Future Returns Will Balance Carrier Focus With Cautious Earnings Assumptions
Analysts have raised their blended price target for Aflac by about $0.20 per share, citing recent stock performance, generally strong life insurance results in Q1, and roll-forward valuation work that now places greater emphasis on carriers rather than brokers. Analyst Commentary Recent Street research on Aflac shows a mix of optimism around execution and caution around valuation and earnings power, with several price target changes in both directions.Seeking Alpha • May 06
Aflac: An Insurer To Buy After Impressive Q1 Results, Even As Valuation Rises
Summary Aflac remains a Buy despite a Q1 earnings miss, supported by organic policy growth, proven dividend increases, and robust balance sheet strength. Growth catalysts include new policy sales, expanding Asian market presence, and niche segments like pet insurance, though revenue trends remain uneven. Margins and expense ratios are favorable, with A-level credit ratings and conservative leverage, but forward P/E multiples signal some overvaluation and more muted near-term upside. Dividend growth (+16% YoY) and a low payout ratio (~30%) reinforce AFL's appeal for income investors, while technicals support a bullish trend as well after a recovery signal. Read the full article on Seeking Alphaナラティブの更新 • May 01
AFL: Future Returns Will Balance Reinsurance Moves With Cautious Earnings Expectations
Narrative Update on Aflac The consensus analyst price target for Aflac has edged lower by a few dollars to $111.86, as analysts factor in more cautious revenue growth assumptions alongside slightly stronger profit margin and future P/E inputs. Analyst Commentary Recent research on Aflac reflects a mixed but mostly cautious tone, with several firms trimming price targets by small amounts and one lifting its target and reinitiating coverage at a neutral stance.ナラティブの更新 • Apr 17
AFL: Future Returns Will Reflect Mixed Earnings Outlook And Product Expansion
Aflac's updated fair value estimate has been trimmed from $113 to about $111.86 as analysts consolidate mixed price target moves. This reflects slightly softer assumptions on revenue growth, profit margins, and future P/E while still seeing support from recent target adjustments across major firms.ナラティブの更新 • Apr 03
AFL: Future Returns Will Reflect Capital Strength And Earnings Execution Risks
Narrative Update The analyst price target framework for Aflac now centers around $113. This reflects updated Street work, with some firms raising targets toward $118 and others trimming into the $101 to $120 range as analysts refresh earnings estimates and extend their valuation horizons.ナラティブの更新 • Mar 20
AFL: Future Returns Will Balance Cybersecurity Fallout And Capital Strength
Narrative update on Aflac The analyst price target framework for Aflac shifts modestly higher toward the recent Street range, reflecting updated EPS roll forward work, a slightly adjusted future P/E assumption to 16.36x, and analysts' mixed but constructive views that blend a higher $118 target with several reductions closer to $101 to $120. Analyst Commentary Recent research on Aflac is mixed, with some bullish analysts nudging targets higher while more cautious voices trim expectations.ナラティブの更新 • Mar 05
AFL: Future Returns Will Weigh Cyber Breach Risks Against Capital Strength
Aflac's updated analyst price target edges higher to about $113, supported by analysts rolling their models to 2027 and 2028 EPS and fine tuning assumptions around slightly stronger profit margins and a modestly lower future P/E multiple. Analyst Commentary Recent Street research on Aflac highlights a mix of optimism and caution as analysts update their models and valuation frameworks out to 2027 and 2028.ナラティブの更新 • Feb 19
AFL: Future Returns Will Balance Cyber Risk And Capital Strength
Analysts now see Aflac's fair value edging up by $1 to $111.69 per share, reflecting adjusted price targets that factor in updated views on revenue growth, profit margins, and future P/E multiples. Analyst Commentary Bullish and cautious voices are both active around Aflac right now, with recent price target trims reflecting fine tuning of expectations rather than a wholesale shift in views on execution or valuation.ナラティブの更新 • Feb 05
AFL: Future Returns Will Reflect Capital Strength Versus Cyber And Insurance Headwinds
Narrative Update: Aflac The analyst price target for Aflac has been trimmed slightly, with a new fair value estimate of about $110.69 compared with $110.85 before. Analysts are factoring in updated sector views on life and P&C insurers, modest tweaks to revenue growth and margin assumptions, and only a small adjustment to future P/E expectations.分析記事 • Jan 30
Aflac's (NYSE:AFL) Dividend Will Be Increased To $0.61
Aflac Incorporated ( NYSE:AFL ) has announced that it will be increasing its dividend from last year's comparable...ナラティブの更新 • Jan 21
AFL: Future Returns Will Balance Capital Strength With Cyber And Sector Headwinds
Narrative Update on Aflac Aflac's updated analyst price target edges lower to about $111, as analysts moderate expectations for revenue growth and margins while still citing capital strength, cash flow, and sector consolidation as key supports. Analyst Commentary Recent research on Aflac reflects a mix of optimism about capital strength and cash flow, alongside caution around industry headwinds and valuation expectations.ナラティブの更新 • Jan 06
AFL: Future Returns Will Reflect Stable Earnings Power And Capital Returns Balancing Cyber Risks
Analysts made only a small adjustment to their Aflac fair value estimate, with the target price moving from about $111.08 to $111.31 as they factor in recent price target revisions across the sector, softer pricing trends in some insurance lines, and generally steady modeling updates following calm recent earnings seasons. Analyst Commentary Street research around Aflac reflects a mix of optimism on company specific execution and caution around broader insurance pricing trends, which feeds into relatively modest adjustments to fair value estimates.ナラティブの更新 • Dec 15
AFL: Future Performance Will Reflect Claims Tailwinds And Balanced Capital Return Execution
Analysts have modestly raised their price targets on Aflac, with recent upward revisions ranging from approximately $5 to $6 per share. They cite better than expected life insurance earnings, favorable claims experience, and resilient earnings trends despite macro uncertainties.ナラティブの更新 • Dec 01
AFL: Future Performance Will Reflect Strength In Claims And Distribution Execution
Aflac's analyst price target increased modestly, with recent updates reflecting improved life insurance earnings and stable macro conditions as key factors cited by analysts. Analyst Commentary Recent updates from street research highlight several factors influencing Aflac's valuation targets, with analysts weighing both potential growth drivers and areas of caution.分析記事 • Nov 18
Aflac's (NYSE:AFL) Dividend Will Be $0.58
The board of Aflac Incorporated ( NYSE:AFL ) has announced that it will pay a dividend on the 1st of December, with...ナラティブの更新 • Nov 16
AFL: Future Earnings Outlook Will Reflect Improving Claims And Distribution Strength
The analyst price target for Aflac has increased modestly, with a $1 uptick in fair value to $111.00. Analysts point to stable industry conditions and improving claims experience supporting the outlook.ナラティブの更新 • Nov 01
AFL: Earnings Stability And Strong Buybacks Will Support Balanced Outlook
Analysts have increased their price targets for Aflac, with upward revisions ranging from $1 to $6 per share. They cite stable earnings performance, as well as positive impacts from new product sales and favorable claims experience.ナラティブの更新 • Oct 18
Custom Cancer Insurance And Digital Underwriting Will Drive Future Expansion
Aflac's analyst price target has been increased from $108.31 to $110.00. Analysts cite steady improvements in revenue growth, profit margins, and favorable claims experience as key factors supporting the upward revision.ナラティブの更新 • Oct 04
Custom Cancer Insurance And Digital Underwriting Will Drive Future Expansion
Aflac's analyst price target has been raised slightly, with an increase of $2 to $108. Analysts highlight strong Q2 sales driven by new product rollouts and improved net interest income.Seeking Alpha • Jan 08
Aflac's Shares Are Overvalued
Summary Aflac Incorporated's heavy reliance on Japan, a market with weak long-term growth prospects, leads to relatively muted growth and significant currency risk exposure. Despite its strong financial position, Aflac's premium valuation compared to peers is unjustified given its average earnings momentum and low dividend yield. Aflac's strategy focuses on attracting younger customers in Japan but faces structural challenges due to the country's aging and shrinking population. For long-term investors, Manulife offers a better risk-reward proposition in the insurance sector compared to Aflac. Read the full article on Seeking AlphaSeeking Alpha • Nov 02
Insurer Aflac Quacks Away At Policy Growth And Low Debt Risk
Summary Aflac gets upgraded to Buy from my prior hold rating a year ago, driven by policy growth & retention in Q3 despite net earnings loss. Although the stock trades near a 10-year-high, it is still undervalued to key peers in terms of fwd P/E and trailing P/B ratios. A trend of dividend growth looks to continue its sustainability. The firm has low debt-to-equity vs peers, with strong credit ratings. Despite a large size of the market, Aflac is in a competitive industry with several large insurance brands to compete with. Read the full article on Seeking AlphaSeeking Alpha • Aug 26
Aflac: Double Digit Dividend Growth And Strong Portfolio Of Investments
Summary Aflac (AFL) has demonstrated financial strength through its increased revenue, net investment gains, and decreased benefits and claims. The current dividend yield remains modest at 1.8% but the dividend growth rate sits in the double digits. This is accompanied by an extremely health payout ratio. AFL's portfolio of debt investments, including middle market loans and commercial real estate, has helped generate higher revenues, but vulnerability exists with potential interest rate cuts and poor credit ratings. Read the full article on Seeking AlphaSeeking Alpha • Apr 22
Aflac Incorporated: Good Positioning But Risks From Japan
Summary Aflac recently reached its all-time high price, but has been showing signs of uncertainty lately. The company possesses a strong business foundation, poised to sustain a steady level of revenue in the foreseeable future, but exposure to macroeconomic scenarios creates uncertainty. I think it would be wise to hold off for now and monitor how the company adapts to the macroeconomic environment. There’s a chance we could buy in at a lower price later on. Read the full article on Seeking AlphaSeeking Alpha • Apr 09
Aflac: Growing Cancer Cases Will Lead To Higher Revenues
Summary Aflac remains a strong dividend-growth company, with a history of increasing dividends for 41 consecutive years. Cancer insurance sales are expected to be a major catalyst for long-term growth in both the Japanese and US markets. Despite missing revenue expectations in the latest earnings report, AFL's financials and outlook remain positive, with a focus on reducing expenses and increasing margins to mitigate short-term decreases. The dividend has grown at a double-digit CAGR over the last five-year period. Read the full article on Seeking Alpha株主還元
| AFL | US Insurance | US 市場 | |
|---|---|---|---|
| 7D | -2.0% | -1.1% | 1.4% |
| 1Y | 11.8% | -5.4% | 25.7% |
業界別リターン: AFL過去 1 年間で-5.4 % の収益を上げたUS Insurance業界を上回りました。
リターン対市場: AFLは、過去 1 年間で25.7 % のリターンを上げたUS市場を下回りました。
価格変動
| AFL volatility | |
|---|---|
| AFL Average Weekly Movement | 2.4% |
| Insurance Industry Average Movement | 4.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
安定した株価: AFL 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。
時間の経過による変動: AFLの 週次ボラティリティ ( 2% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1955 | 12,716 | Dan Amos | www.aflac.com |
アフラック・インコーポレーテッドは子会社を通じて医療・生命保険商品を提供している。アフラック・ジャパンおよびアフラックU S.の2つのセグメントで事業を行っている。アフラック・ジャパンのセグメントでは、日本でがん保険、医療保険、介護保険、終身保険、GIFT保険、WAYS保険、こども養老保険、つみたす保険を提供している。アフラック米国部門は、米国で傷害保険、障害保険、がん保険、重大疾病保険、病院補償保険、歯科保険、視力保険、生命保険商品を提供している。同社はまた、聴力保険、終身費用保険、ペット保険、メディケア補助保険、歯科・視力補助保険、短期障害保険、休業管理保険、カフェテリアプランも提供している。個人、独立法人、提携法人代理店、銀行、独立アソシエーツ／キャリア代理店、ブローカーを通じて、個人、家族、企業オーナーに商品を販売している。アフラックは1955年に設立され、ジョージア州コロンバスに本社を置いている。
Aflac Incorporated 基礎のまとめ
| AFL 基礎統計学 | |
|---|---|
| 時価総額 | US$58.77b |
| 収益（TTM） | US$4.64b |
| 売上高(TTM) | US$18.11b |
12.7x
PER（株価収益率3.2x
P/SレシオAFL は割高か？
公正価値と評価分析を参照収益と収入
| AFL 損益計算書（TTM） | |
|---|---|
| 収益 | US$18.11b |
| 売上原価 | US$9.05b |
| 売上総利益 | US$9.07b |
| その他の費用 | US$4.43b |
| 収益 | US$4.64b |
直近の収益報告
Mar 31, 2026
次回決算日
Aug 06, 2026
| 一株当たり利益（EPS） | 9.11 |
| グロス・マージン | 50.05% |
| 純利益率 | 25.60% |
| 有利子負債／自己資本比率 | 48.0% |
AFL の長期的なパフォーマンスは？
過去の実績と比較を見る配当金
2.1%
現在の配当利回り27%
配当性向企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/06/20 12:41 |
| 終値 | 2026/06/18 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Aflac Incorporated 9 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。30
| アナリスト | 機関 |
|---|---|
| Taylor Scott | Barclays |
| Jay Gelb | Barclays |
| Jack Matten | BMO Capital Markets Equity Research |